Citron's Left Reiterates Belief AbbVie Shares Will Fall Sharply

By REUTERS
NYT
Short-seller Andrew Left's Citron Research expanded on his prediction that U.S. drugmaker AbbVie Inc's stock would fall to $60 a share, arguing that new regulations to speed biosimilar drugs to the market and reform rebates will hurt revenue from ...
Published date: July 24, 2018 at 11:09PM
Reuters
New York Times article